96667 ⎘
Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from animals; from humans
T-CELL EXPANSION METHOD AND USES
#2T-CELL EXPANSION METHOD AND USES
#3SUBSTRATES COMPRISING ELASTIN-LIKE POLYPEPTIDES AND CALCIUM IONS
#4NEOANTIGENS AND USES THEREOF
#5COMPOSITIONS, ASSAYS, AND METHODS FOR TARGETING HDM2 AND HDMX TO REVERSE THE INHIBITION OF p53 IN PEDIATRIC CANCERS
#6NEOANTIGENS AND METHODS OF THEIR USE
#7NEOANTIGENS AND METHODS OF THEIR USE
#8COMPOUND FOR THE SEQUESTRATION OF UNDESIRABLE ANTIBODIES IN A PATIENT
#9PEPTIDES DERIVED FROM MELANOMA-ASSOCIATED ANTIGEN C2 (MAGEC2) AND USES THEREOF
#10Methods for Treating Breast Cancer and for Identifying Breast Cancer Antigens
#11BIOMARKERS AND METHODS FOR PREDICTING PRETERM BIRTH
#12Anti-inflammatory compounds and methods of use
#13Neoantigens and uses thereof
#14PEPTIDES
#15PEPTIDES DERIVED FROM MELANOMA-ASSOCIATED ANTIGEN C2 (MAGEC2) AND USES THEREOF
#16Anti-inflammatory compounds and methods of use
#17Method of producing an active-form mutant enzyme
#18Cultured phagocyte supernatent compositions
#19T-CELL EXPANSION METHOD AND USES
#20Peptides with vasodilatory and/or diuretic functions
#21COMPOSITIONS, ASSAYS, AND METHODS FOR TARGETING HDM2 AND HDMX TO REVERSE THE INHIBITION OF p53 IN PEDIATRIC CANCERS
#22Isolated polypeptide and compositions comprising same
#23THERAPEUTIC PEPTIDES AND METHODS OF USE THEREOF
#24PEPTIDES
#25PEPTIDES
#26Methods for treating breast cancer and for identifying breast cancer antigens
#27Anti-inflammatory compounds and methods of use
#28Peptide having antimicrobial activity against pathogens and antimicrobial peptide composition comprising the same
#29Method of producing an active-form mutant enzyme
#30Pharmaceutical composition for treating and/or preventing cancer
#31Peptide for promoting hair growth
#32Photoremovable protecting groups and uses thereof
#33P38 MAPK INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES
#34Synthetic anti-inflammatory peptides and use thereof
#35Use of PEDF-derived polypeptides for treating osteoarthritis
#36Antigen peptide derived from the sequence of epidermal growth factor receptor having T790M point mutation
#37IgE CH3 peptide vaccine
#38Peptide vaccines for cancers expressing tumor-associated antigens
#39LRP1 as key receptor for the transfer of sterified cholesterol from very-low-density lipoproteins (VLDL) to ischaemic cardiac muscle
#40Peptide vaccines for cancers expressing tumor-associated antigens
#41Therapeutic peptides and use thereof against huntington's disease
#42Cancer therapies and diagnostics
#43Peptide vaccines for cancers expressing tumor-associated antigens
#44Compounds and methods for purifying peptides produced by solid phase peptide synthesis
#45Human milk peptides
#46IgE CH3 peptide vaccine
#47INHBB EPITOPE PEPTIDES AND VACCINES CONTAINING THE SAME
#48Peptide vaccines for cancers expressing tumor-associated antigens
#49Zinc-charged peptides for the treatment of cancer and alzheimer's disease
#50Non-toxic skin cancer therapy with copper peptides